Organization · Corporate Venture Capital
CS Ventures
CS Ventures is the corporate venture arm of Canterbury Scientific Ltd., based in New Zealand. It focuses on investing in early-stage in vitro diagnostic technologies globally, leveraging its parent company's expertise in manufacturing and regulatory processes.
Overview
What CS Ventures does
What CS Ventures is
CS Ventures is the corporate venture arm of Canterbury Scientific Ltd., based in New Zealand. It focuses on investing in early-stage in vitro diagnostic technologies globally, leveraging its parent company's expertise in manufacturing and regulatory processes.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find CS Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
CS Ventures as a funder
Investment thesis
CS Ventures invests in novel in vitro diagnostic technologies that align with Canterbury Scientific's manufacturing specialties, focusing on proprietary biomarkers, lateral flow applications, and scalable protein purification.
Focus narrative
CS Ventures exclusively invests in innovative in vitro diagnostic technologies that align with Canterbury Scientific’s manufacturing specialties. The organization is particularly interested in technologies that incorporate proprietary biomarkers, lateral flow applications, non-standard biological fluid controls, and scalable protein purification. They target technologies at or beyond the human proof of concept and prototype stage (TRL 4+) with robust intellectual property.
Value beyond capital
CS Ventures combines capital with scientific, regulatory, and manufacturing support, leveraging Canterbury Scientific's expertise to help portfolio companies scale their technologies effectively. This strategic alignment enhances the potential for success in the diagnostics market.
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 3
Portfolio context
Notable investments include: Aptatek Biosciences (USA): Developing innovative IVD solutions for chronic disease monitoring. MiMARK (Spain): Advancing diagnostic technologies in the IVD space. Vivodyne: Utilizing lab-grown human organ systems for drug testing, participating in a recent seed round.
Common questions
What to know about CS Ventures
Upseed classifies CS Ventures under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.